CN111693616A
|
|
Method for measuring B vitamins in blood sample by liquid chromatography tandem mass spectrometry
|
CN111693615A
|
|
Analytical method for simultaneous determination of niacin, vitamin B1, B6 and pantothenic acid
|
CN112179996A
|
|
High performance liquid chromatography analysis method for determining vitamin A in complex components
|
CN112168802A
|
|
Capsule for improving intestinal flora of hypertension patient
|
CN112034052A
|
|
Method for determining vitamin B in complex components2High performance liquid chromatography analysis method
|
CN109738662A
|
|
A kind of POCT Biochemical Analyzer with multi-channel detection
|
CN111588857A
|
|
Pharmaceutical composition containing amlodipine, chlorthalidone and aldosterone receptor antagonist
|
CN110786515A
|
|
Vitamin composition for improving cerebral apoplexy prognosis and application thereof
|
CN110237258A
|
|
For treating the pharmaceutical composition of hypertension
|
CN109939077A
|
|
A kind of controlled release preparation containing 5-methyltetrahydrofolate
|
CN109864978A
|
|
A kind of sustained release preparation of 5-methyltetrahydrofolate and preparation method thereof
|
CN106942747A
|
|
A kind of health food for being applied to the elderly
|
CN106310278A
|
|
Multi-cascade antihypertensive drug composition containing folic acid
|
CN106310276A
|
|
Pharmaceutical composition containing sugar and lipid reducing medicine and aspirin and folic acid
|
CN106310277A
|
|
Pharmaceutical composition containing sugar reducing medicine, aspirin and folic acid
|
CN106310274A
|
|
Pharmaceutical composition for preventing cardiovascular diseases
|
CN106310273A
|
|
Quadruple antihypertensive drug composition
|
CN106310272A
|
|
Triple-hypertensive pharmaceutical composition
|
CN106310271A
|
|
Pharmaceutical composition for treating chronic heart failure
|
CN106310270A
|
|
Medicine composition of angiotensin converting enzyme inhibitor and neprilysin inhibitor
|